Neurological Outcomes After In-Hospital Cardiac Arrest

NCT ID: NCT03006484

Last Updated: 2020-05-13

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

322 participants

Study Classification

OBSERVATIONAL

Study Start Date

2017-03-21

Study Completion Date

2020-02-03

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Little is known about the long-term neurological outcomes after in-hospital cardiac arrest (IHCA). It is also not known whether withdrawal of life-sustaining measures will influence rates of survivors with poor neurological status. Currently, withdrawal of care in comatose patients after cardiac arrest is strongly forbidden by law in Korea. However, a new legislation on allowing withdrawal of care will come into effect since early 2018 in Korea. The investigators aim to determine 1) long-term neurological outcomes in patients who developed IHCA, 2) whether early neurological status can predict late neurological status after IHCA, and 3) whether the proportion of IHCA survivors with good neurological outcomes will change since implementation of new legislation on withdrawal of care.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

\<The schedule of assessment\>

* Day 0: Neurological examination (First examination will be performed within 2 hours after IHCA)
* Day1 - 7: Neurological examination
* Day7, 14, 21, 28: Neurological examination, CPC score
* Day90: CPC score, survival
* Day180: CPC score, survival
* Day 360: CPC score, survival

\<Cerebral Performance Category(CPC) score\>

* CPC 1: good cerebral performance
* CPC 2: Moderate cerebral disability(available for independent activities)
* CPC 3: Severe cerebral disability(dependent on others for daily support)
* CPC 4: Coma or vegetative state
* CPC 5: Brain death or death

\<Acronyms\>

* ACDU(Alert/Confused/Drowsy/Unresponsive) score
* FOUR(Full Outline of Unresponsiveness) score

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Inhospital Cardiac Arrest

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Before Period

Patients who developed in-hosptial cardiac arrest before the implementation of new legislation on life-sustaining treatments

No interventions assigned to this group

After Period

Patients who developed in-hosptial cardiac arrest after the implementation of new legislation on life-sustaining treatments

No intervention

Intervention Type OTHER

No intervention will be needed.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

No intervention

No intervention will be needed.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age ≥ 18
* In-hospital cardiac arrest
* Cardiopulmonary Resuscitation(CPR) code activation and/or neurology consultation for IHCA

Exclusion Criteria

* Neither (CPR) code activation nor neurology consultation
* Development of IHCA during transition period
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Asan Medical Center

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Sang-Beom Jeon

Associate Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Sang-Beom Jeon, Master

Role: PRINCIPAL_INVESTIGATOR

Asan Medical Center

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Asan Medical Center

Seoul, Songpa-gu, South Korea

Site Status

Countries

Review the countries where the study has at least one active or historical site.

South Korea

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2016-1378

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.